MDV-1 VP22/HPV16 E7 DNA vaccine (Johns Hopkins University)

N/A

Report date: 2025/03/20 15:47:49

Base Information

Drug NameMDV-1 VP22/HPV16 E7 DNA vaccine (Johns Hopkins University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine +[4] 
Mechanisms of ActionProtein E7 modulators
TargetsProtein E7
Therapy Area/IndicationsNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsNeoplasmsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A